Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13Carcinoma, Non-Small-Cell Lung 11Neoplasm Metastasis 7Brain Neoplasms 7Rectal Neoplasms 6Lung Neoplasms 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Urinary Bladder Neoplasms 4Prostatic Neoplasms 4Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Melanoma 3Glioblastoma 3Colorectal Neoplasms 3Colonic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Inflammatory Breast Neoplasms 2Glioma 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma 2Vaginal Neoplasms 1

Interventions

Surgical Procedures, Operative 1Fluorouracil 1Drug Therapy 1Cisplatin 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Localized Resectable Adult Primary Liver Cancer × Surgical Procedures, Operative × Clear all
NCT00238160 2013-05-30

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

National Cancer Institute (NCI)

Phase 3 Withdrawn

Localized Resectable Adult Primary Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡